FASENRA PEN Trademark

Trademark Overview

On Thursday, October 18, 2018, a trademark application was filed for FASENRA PEN with the United States Patent and Trademark Office. The USPTO has given the FASENRA PEN trademark a serial number of 88160463. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, May 9, 2025. This trademark is owned by AstraZeneca AB. The FASENRA PEN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the prevention and treatment of respiratory diseases and disorders
fasenra pen

General Information

Serial Number88160463
Word MarkFASENRA PEN
Filing DateThursday, October 18, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, May 9, 2025
Registration Number5951274
Registration DateTuesday, December 31, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the prevention and treatment of respiratory diseases and disorders
Translation of Words in MarkThe wording "FASENRA" has no meaning in a foreign language.
NOT AVAILABLE"PEN"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 31, 2018
Primary Code005
First Use Anywhere DateMonday, October 28, 2019
First Use In Commerce DateMonday, October 28, 2019

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Monday, October 22, 2018NEW APPLICATION ENTERED
Wednesday, October 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 8, 2019ASSIGNED TO EXAMINER
Thursday, January 10, 2019NON-FINAL ACTION WRITTEN
Thursday, January 10, 2019NON-FINAL ACTION E-MAILED
Thursday, January 10, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 1, 2019ASSIGNED TO LIE
Tuesday, July 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 11, 2019TEAS STATEMENT OF USE RECEIVED
Monday, November 11, 2019USE AMENDMENT FILED
Wednesday, November 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 20, 2019STATEMENT OF USE PROCESSING COMPLETE
Sunday, November 24, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 26, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 31, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 17, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, May 9, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 9, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 9, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 31, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

fasenra respiratory diseases disorders treatment prevention preparations substances pharmaceutical